White House Announces Agricultural and Rare Earths Deals Following TrumpXi Summit Zscaler Shares Plunge 31 in Record Drop on Cautious Outlook and Sales Reorganization Tax Season 2025 New Rules for Online Sellers and EV Buyers Could Boost Refunds Donald Trump JrBacked Enhanced Games Set for Sunday Debut with Broader Expansion Plans Meta Launches Paid Plans for Instagram Facebook and First AI Subscription Presidential Tariff Authority Expands Beyond Steel and Aluminum New Trade Policy Dimensions Processa Pharmaceuticals PCSA Q4 2025 Earnings EPS Misses Estimates by a Wide Margin as PreRevenue Biotech Advances Pipeline SYNA Q1 2026 Earnings EPS Surpasses Estimates Shares Surge ANRO Q1 2026 Earnings Significant EPS Miss Highlights EarlyStage Development Costs KELYA Q1 2026 Earnings EPS Miss of 6026 Despite Positive Stock Reaction MNDY Q1 2026 Earnings Strong EPS Beat Highlights Operational Discipline DFLI Q1 2026 Earnings WiderthanExpected Loss Reflects Continued RD Investment BOK Financial Corporation BOKF Nudges Higher Testing Resistance Near 139 Indigo Acquisition Corp Unit INACU Holds Steady at 1028 as SPAC Units Trade in Tight Range UNITIL Corporation UTL Holds Steady Near Support as Utility Sector Consolidates Schrodinger Inc SDGR Shows Modest Uptick Amid Key Resistance Test Trimble Inc TRMB Declines Nearly 3 Approaching Key Support at 5193 Gokaldas Exports Reports 9 Sequential Revenue Growth in Q4 Despite Global Trade Challenges Australia Launches Historic A2 Billion Lawsuit Against 3M Over PFAS Contamination at Defence Sites Morningstar Identifies Healthcare Stocks as Attractive Investment Opportunities Tokenization Could Reshape Credit Markets and Challenge Traditional Banks Says Strategys Michael Saylor QXO Launches Hostile Takeover Bid for BuildingProducts Rival Beacon Jim Cramer Spotlights 4 Portfolio Stocks as AI Sector Diversification Opportunity UK Hottest Day of Year Boosts Travel Sectors Amid Bank Holiday Queues STSS Q3 2025 Earnings EPS Misses Estimates by a Wide Margin as Revenue Remains Unreported Definium Therapeutics DFTX Retreats Marginally as Key Support Holds at 2138